Utility of Point-of-care Device for Rapid Determination of Cogulopathy in Trauma Patients
Coaguchek
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Traumatic coagulopathy is frequent and is an independent risk factor of mortality. Its detection mainly relies upon classic biological test like the prothrombin time and the international normaliezd ratio (INR). These tests are not available at the bedside. Point of care (POC) device for INR measurement are now available like the Coaguchek, Roche, France. The aim of the present study is to test the correlation between the POC INR and the laboratory INR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 9, 2016
CompletedFirst Posted
Study publicly available on registry
August 17, 2016
CompletedAugust 17, 2016
August 1, 2016
1.4 years
August 9, 2016
August 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concordance between POC INR and laboratory INR using 3 classes: normal < 1.1, moderate : 1.1-1.5, severe: >1.5
Admission
Secondary Outcomes (5)
Prediction of RBC transfusion
24 hours post admission
Prediction of FFP transfusion
24 hours post admission
In-hospital mortality assessed using patients' files
up to Day 28
Injury severity (ISS)
Day 1
Organ failure measured with the SOFA score at Day 1
Day 1
Interventions
Capillary puncture for POC INR measurement
Eligibility Criteria
Patients admited for a suspicion of severe trauma wirth active bleeding in a level I trauma center
You may qualify if:
- Age \> 15 y-o
- Admission for severe trauma
You may not qualify if:
- Patients under oral anticoagulant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Mistral T, Boue Y, Bosson JL, Manhes P, Greze J, Brun J, Albaladejo P, Payen JF, Bouzat P. Performance of point-of-care international normalized ratio measurement to diagnose trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2017 Jun 21;25(1):59. doi: 10.1186/s13049-017-0404-y.
PMID: 28637514DERIVED
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2016
First Posted
August 17, 2016
Study Start
January 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
August 17, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share